Monday, May 23, 2022 9:53:55 AM
Comparison of the Three Months Ended March 31, 2022 with the Three Months Ended March 31, 2021
Net Revenue. For the three months ended March 31, 2022, we generated revenues of $4,920 as compared to $15,596 for the three months ended March 31, 2021. The decrease revenue was due primarily to a decrease in sales of hemp cigarettes.
Cost of Revenues. For the three months ended March 31, 2022 and 2021, cost of revenue was $1,764 and $11,853, respectively. The decrease was due primarily to lower sales.
Gross Profit. As a result of the foregoing, our gross profit was $3,156 for the three months ended March 31, 2022, compared with $3,743 for the three months ended March 31, 2021.
Operating Expenses. For the three months ended March 31, 2022 and 2021, total operating expenses were $145,922 and $18,444. The increase was primarily due to higher professional and legal expenses related to regulatory filings and potential stock listing.
Net Loss. For the three months ended March 31, 2022 and 2021, net loss was $145,766 and $14,701, respectively. The increase in net loss was primarily due to higher professional and legal expenses.
https://www.sec.gov/Archives/edgar/data/1877461/000147793222003548/onesix_10q.htm
My comments and implied views are provided for entertainment purposes. I am not a certified financial advisor, and I am not qualified to give financial advice. Please do your own due diligence and make your own decisions.
Recent SING News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 10:00:59 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/19/2024 08:48:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/24/2024 09:15:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:46:47 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/22/2024 04:08:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2024 01:51:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:08:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:00:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:41:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 05:22:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 08:30:16 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 12/18/2023 09:36:43 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM